Medicare AdvantagePrior AuthMedium impact
Seglentis® (celecoxib-tramadol) (Revised)
Humana·Pain Management, Orthopedics, General Surgery +2 more·Medicare Advantage
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Seglentis (celecoxib-tramadol) tablets effective January 1, 2025. Members must meet two criteria: using it for severe pain requiring opioid treatment and having previous treatment with celecoxib plus immediate-release tramadol 50mg.
Action Required
Immediately: Billing team must verify prior authorization requirements for Seglentis (celecoxib-tramadol) prescriptions for Medicare Advantage patients. Providers must document that patient is using medication for severe pain requiring opioids and has previous treatment history with celecoxib plus immediate-release tramadol 50mg. Update prior authorization checklists and EMR templates to include these criteria. Claims will be denied without proper prior authorization.